<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Medicortex Finland Oy — New Patents | PatentBrief</title>
    <link>https://patentbrief.org/company/medicortex-finland-oy</link>
    <description>Plain-English explanations of patents assigned to Medicortex Finland Oy, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Sun, 12 Jul 2026 09:26:34 GMT</lastBuildDate>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://patentbrief.org/company/medicortex-finland-oy/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Checking if Brain Injury Drugs Work Using Saliva or Urine</title>
      <link>https://patentbrief.org/patent/us/20200371093/prognostic-and-diagnostic-glycan-based-biomarkers-of-brain-damage</link>
      <description>This patent describes a method to determine if a drug for brain injury is effective by measuring specific sugar molecules in a patient&apos;s saliva or urine samples over time.</description>
      <pubDate>Mon, 06 Jul 2026 10:57:39 GMT</pubDate>
      <guid isPermaLink="true">https://patentbrief.org/patent/us/20200371093/prognostic-and-diagnostic-glycan-based-biomarkers-of-brain-damage</guid>
    </item>
  </channel>
</rss>
